Barclays Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)Tip Ranks·Aug 19 at 02:27 AMCOLL-2.92%
The Infrastructure Bottleneck: When AI Software Meets Physical RealityGlobal Report·Aug 18 at 05:12 AMHUBS+0.26%DOCU+3.55%
Collegium Announces $50 Million Accelerated Share Repurchase ProgramUnusual Whales·Aug 13 at 06:32 AMCOLL-2.92%JEF-0.85%
Collegium Q2 2026 Earnings: Acquisition Costs Push GAAP Results Into a LossTradingKey·Aug 6 at 07:26 AMCOLL-2.92%
Collegium turns to GAAP net loss of $15.1 million in Q2 FY26; revenue rises 6% to $199.9 millionPUBT·Aug 6 at 06:35 AMCOLL-2.92%
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company ProgressUnusual Whales·Aug 6 at 06:34 AMCOLL-2.92%
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To ExpectStock Story·Aug 4 at 10:36 PMCOLL-2.92%
Collegium Pharmaceutical to report Q2 2026 results, host earnings callPUBT·Jul 23 at 07:05 AMCOLL-2.92%
Collegium Pharma To Relocate Corporate Headquarters To Downtown Boston In 2027rttnews·Jul 20 at 09:31 AMCOLL-2.92%
DivcoWest Welcomes Collegium Pharmaceutical to One LincolnUnusual Whales·Jul 20 at 07:47 AMCOLL-2.92%
Collegium Pharmaceutical (COLL) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings##Simplywall·Jul 18 at 12:10 AMCOLL-2.92%
